Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | LA |
anaphylaxis; intubated; This serious case was reported by a other health professional via call center representative and described the occurrence of anaphylaxis in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included shellfish allergy. Concomitant products included lisinopril. On 04-FEB-2025, the patient did not received the 2nd dose of Shingrix (left arm). In FEB-2025, an unknown time after receiving Shingrix, the patient experienced anaphylaxis (Verbatim: anaphylaxis) (serious criteria hospitalization, GSK medically significant, life threatening and clinically significant/intervention required) and intubation (Verbatim: intubated) (serious criteria hospitalization, life threatening and clinically significant/intervention required). The outcome of the anaphylaxis and intubation were not resolved. It was unknown if the reporter considered the anaphylaxis and intubation to be related to Shingrix. The company considered the anaphylaxis and intubation to be unrelated to Shingrix. Additional Information: GSK Receipt Date:10-FEB-2025 Other Healthcare Professional reported that the patient took Shingrix vaccine and experienced anaphylaxis and intubated. The reporter did not consent to follow-up.; Sender's Comments: Anaphylactic reaction is a listed event which, due to the following criteria (concurrent shellfish allergy, insufficient information regarding medical history, completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingrix. Endotracheal intubation is an unlisted event which is considered unrelated to GSK vaccine Shingrix.
Shellfish allergy
LISINOPRIL